First ESCEO-IOF-ERAB Scholarship awarded to Romanian researcher

Scholarship awarded to Otilia Rogoveanu, lead author of a study which found that chronic excessive alcohol consumption increases the risk of developing secondary osteoporosis in young men.

The ESCEO-IOF-ERAB Scholarship was presented at the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases 2018 in Krakow, Poland, in recognition of exceptional research by a PhD or Post doc student working on the impact of alcohol consumption on osteoporosis and/or the risk of fragility fracture.

The winner of the 2018 Scholarship, offered by ESCEO, IOF and the European Foundation for Alcohol Research (ERAB), is Dr Otilia Rogoveanu from the University of Medicine and Pharmacy (UMF) Craiova, Romania. She is the lead author of a study by a research team from the UMF Craiova which looked at whether chronic, excessive alcohol consumption increases the risk of secondary osteoporosis in relatively young men.

The study included 80 men aged between 30 and 50 years who had been diagnosed with liver disease at the Gastroenterology Clinic of the Craiova Emergency County Clinical Hospital and were subsequently monitored in the Medical Rehabilitation Clinic in regard to osteoporosis. Only patients with no risk factors or other potential causes of secondary osteoporosis were included in the study. The patients were equally divided into two groups whereby the first group included patients affected by alcoholic liver disease, and the second group consisted of patients diagnosed with liver diseases of viral etiology.

Following testing, it was shown that 36 out of 40 patients (90%) in the first group, compared to only 10 out of 40 patients in the second group, had low T-scores suggesting osteoporosis.

The findings confirm that chronic, excessive alcohol consumption increases the risk of developing secondary osteoporosis in young men, with direct repercussions on their health status and work capacity.

Abstracts from WCO-IOF-ESCEO Kraków 2018 have been published in the scientific journal ‘Osteoporosis International’, Volume 29, Supplement 1, 2018.

World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Kraków 2018)

Held jointly by IOF and ESCEO, the Congress takes place in Kraków, Poland, from April 19-22, 2018. WCO-IOF-ESCEO is the world’s largest annual forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. For complete information visit  #OsteoCongress

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 240 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority.  @iofbonehealth


The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.